MedPath

Fludarabine Phosphate

Fludarabine Phosphate Injection Unapproved Drug_Shortage

Approved
Approval ID

ebff8bde-0e6e-4689-bf8c-5c56c119e323

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 25, 2023

Manufacturers
FDA

Teva Pharmaceuticals, Inc.

DUNS: 022629579

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fludarabine Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0480-9772
Product Classification
G
Generic Name
Fludarabine Phosphate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 25, 2023
FDA Product Classification

INGREDIENTS (4)

FLUDARABINE PHOSPHATEActive
Quantity: 25 mg in 1 mL
Code: 1X9VK9O1SC
Classification: ACTIB
SODIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: 94255I6E2T
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fludarabine Phosphate - FDA Drug Approval Details